Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma

Cheng Wang,1,2,* Jianhua Wang,1,* Wenjing Cui,1,* Yongkang Liu,1 Hao Zhou,1 Yajie Wang,1 Xin Chen,1 Xiao Chen,1 Zhongqiu Wang1 1Department of Radiology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, People’s Republic of China; 2Department of Radiology,...

Full description

Bibliographic Details
Main Authors:	Wang C, Wang J, Cui W, Liu Y, Zhou H, Wang Y, Chen X, Wang Z
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	OncoTargets and Therapy
Subjects:	exosome mirna pancreatic ductal adenocarcinoma mirna-1226-3p
Online Access:	https://www.dovepress.com/serum-exosomal-mirna-1226-as-potential-biomarker-of-pancreatic-ductal--peer-reviewed-article-OTT

Similar Items

miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1
by: Na Ta, et al.
Published: (2018-11-01)

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
by: Shiwei Guo, et al.
Published: (2021-09-01)

A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma
by: Yuchen Zhang, et al.
Published: (2020-02-01)

Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma
by: Wu Y, et al.
Published: (2020-08-01)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
by: Ruining Gong, et al.
Published: (2020-03-01)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018-01-01)

Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
by: Moritz Reese, et al.
Published: (2020-01-01)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
by: Victoria Heredia-Soto, et al.
Published: (2021-04-01)

Exosomal miRNA signatures of pancreatic lesions
by: Caterina Vicentini, et al.
Published: (2020-05-01)

microRNA based prognostic biomarkers in pancreatic Cancer
by: Shixiang Guo, et al.
Published: (2018-05-01)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
by: Shao H, et al.
Published: (2021-03-01)

Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
by: Ida Manna, et al.
Published: (2020-09-01)

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR‐29 family
by: Jing Li, et al.
Published: (2021-01-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Inhibition of Circulating Exosomal miRNA-20b-5p Accelerates Diabetic Wound Repair
by: Chen K, et al.
Published: (2021-01-01)

Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
by: Ye Lu, et al.
Published: (2021-08-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

The Regulation of Exosome-Derived miRNA on Heterogeneity of Macrophages in Atherosclerotic Plaques
by: Ximing Li, et al.
Published: (2020-09-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases
by: Lin Wang, et al.
Published: (2020-04-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
by: Lin Y, et al.
Published: (2017-12-01)

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
by: Liao X, et al.
Published: (2017-09-01)

A Highly Responsive Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Rare Case Report
by: Xu Y, et al.
Published: (2021-02-01)

Exosomal MiRNAs in Pediatric Cancers
by: Angela Galardi, et al.
Published: (2019-09-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer
by: Lei Wang, et al.
Published: (2021-09-01)

Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
by: Susan R. Pfeffer, et al.
Published: (2015-12-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma
by: Yan Li, et al.
Published: (2020-01-01)

Modulation of FoxO1 Expression by miR-21 to Promote Growth of Pancreatic Ductal Adenocarcinoma
by: Weifeng Song, et al.
Published: (2015-01-01)

Advances in the diagnosis of exosomal miRNAs in ischemic stroke
by: Yu P, et al.
Published: (2019-08-01)

The Role of Exosomal miRNAs in Glioma: Biological Function and Clinical Application
by: Yirizhati Aili, et al.
Published: (2021-09-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis
by: Chuangen Guo, et al.
Published: (2018-10-01)

Application of the High-Throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma
by: Chang Zeng, et al.
Published: (2019-08-01)

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing
by: Wenli Zhou, et al.
Published: (2021-05-01)